Clinical Trials Browser

Phase 3 × Fentanyl × Tumor-Agnostic × Clear all

NCT00362583 2012-05-07

Efficacy and Safety of Intranasal Fentanyl in the Treatment of Breakthrough Pain (FT-018-IM)

Phase 3 Completed

Neoplasms